Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ronkyla Plus (Glonova Limited)
- Development stage
- Unknown
- Lead developer
- Jing Diamond Biomedical
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Administration
- Intralesional
01
Overview
Ronkyla Plus is a hydrogel-forming sodium deoxycholate injection developed by Glonova Pharma Co., Ltd for the treatment of superficial lipoma and submental fullness. The active ingredient, sodium deoxycholate (also known as deoxycholic acid), is a bile salt that acts as a detergent to induce adipocyte lysis by disrupting fat cell membranes. This localized destruction of fat cells leads to a reduction in fat volume. Ronkyla Plus is uniquely formulated to form a hydrogel at the injection site upon administration, which is intended to provide a better patient experience and potentially improved efficacy compared to traditional lipolysis injections like Kybella. It is currently in Phase 1 clinical development to evaluate its safety, efficacy, and pharmacokinetics for its target indications.
- Brand names
- Ronkyla Plus
- Other names
- sodium deoxycholate hydrogel injectiondeoxycholic acid hydrogelsodium deoxycholatedeoxycholic acid
Beyond the preview
Go deeper on Ronkyla Plus (Glonova Limited).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ronkyla Plus (Glonova Limited).